SCHEMBL6742841

SCHEMBL6742841

OCc1ccc(-c2cnns2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 2/20 0.42
RUNX1 Q01196 2/20 0.42
CBFB Q13951 2/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
GFER P55789 1/20 0.42
FYN P06241 11/20 0.38
PTGS1 P23219 1/20 0.34
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
MAP2K4 P45985 1/20 0.33
TSHR P16473 1/20 0.33
KDM1A O60341 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1145924 0.82 HRH3 (0.50) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL12158655 0.81 ALDH1A1 (0.38) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL6742050 0.81 ALDH1A1 (0.38) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL13514057 0.78 MAPT (0.41) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL9133922 0.78 MAPT (0.60) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL10131071 0.77 MAPT (0.38) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL8274326 0.77 ESR1 (0.41) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL6703533 0.77 ALDH1A1 (0.35) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL6740524 0.74 ALDH1A1 (0.41) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL6740529 0.74 ALDH1A1 (0.41) ALDH1A1GAAMAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6610731-B2 Antiinflammatory BRISTOL-MYERS SQUIBB COMPANY 2003-08-26 US disclosed
US-6403632-B1 CYCLIC AMIDE DERIVATIVE BRISTOL MYERS SQUIBB PHARMA CO (US) 2002-06-11 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed
US-6057336-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-05-02 US disclosed